The Peripheral Intervention Drug-Eluting Devices industry plays a crucial role in improving patient outcomes through innovative medical solutions. This market analysis article aims to provide an overview of Peripheral Intervention Drug-Eluting Devices, their applications, current industry status, and future prospects. In 2022, the global Peripheral Intervention Drug-Eluting Devices market size was estimated at US$5796 million, with a projected compound annual growth rate (CAGR) of 7.8%.
Definition and Applications:
Peripheral Intervention Drug-Eluting Devices are advanced medical devices used primarily in Drug-Eluting Balloons (DEBs) and Drug-Eluting Stents (DES). These devices incorporate specialized pharmaceutical coatings that release therapeutic drugs gradually to prevent restenosis and promote healing. DEBs and DES are commonly employed in diverse peripheral interventions, including vascular, neurology, and oncology procedures.
Industry Status:
The Peripheral Intervention Drug-Eluting Devices industry is witnessing significant growth due to several factors. Firstly, the rising prevalence of diseases requiring peripheral interventions, such as peripheral artery disease and coronary artery disease, drives the demand for drug-eluting solutions. Additionally, the increasing adoption of minimally invasive procedures and advancements in drug-eluting technologies contribute to the industry's growth.
Global manufacturers:
The market is dominated by major global manufacturers who specialize in producing high-quality and effective Peripheral Intervention Drug-Eluting Devices. These manufacturers include:
Medtronic plc: Medtronic is renowned for its comprehensive portfolio of drug-eluting devices, which contribute to managing multiple vascular conditions.
Boston Scientific Corporation: Boston Scientific offers a wide range of innovative drug-eluting solutions, including DEBs and DES, known for their efficacy in peripheral interventions.
Abbott Laboratories: Abbott Laboratories is a leading player in the Peripheral Intervention Drug-Eluting Devices market, particularly known for their DES platforms.
Cardinal Health: Cardinal Health provides drug-eluting solutions designed to enhance patient outcomes and improve procedural efficacy.
B. Braun Melsungen AG: B. Braun Melsungen offers drug-eluting technologies designed to address various peripheral intervention needs.
Biosensors International Group Ltd.: Biosensors International focuses on developing cutting-edge drug-eluting solutions for improved patient care.
C.R. Bard, Inc.: C.R. Bard specializes in drug-eluting technologies that cater to the specific requirements of peripheral interventions.
St. Jude Medical, Inc.: St. Jude Medical offers a range of innovative drug-eluting devices, demonstrating its commitment to advancing peripheral intervention treatments.
The Lubrizol Corporation: The Lubrizol Corporation is known for its drug-eluting coatings that enhance the performance and durability of peripheral intervention devices.
Terumo Corporation: Terumo Corporation provides drug-eluting solutions that contribute to the successful treatment of various peripheral conditions.
Future Prospects:
The future prospects of the Peripheral Intervention Drug-Eluting Devices industry are promising. With an anticipated CAGR of 7.8% between 2022 and beyond, the market is expected to witness substantial growth. Factors contributing to this positive outlook include the growing aging population, increasing prevalence of peripheral artery diseases, and ongoing advancements in drug-eluting technologies. Additionally, the expansion of healthcare infrastructure in emerging markets presents untapped opportunities for market players to penetrate new geographical regions.
Conclusion:
The Peripheral Intervention Drug-Eluting Devices industry is a vital component of modern healthcare, providing innovative solutions for peripheral interventions. With a projected market size of US$5796 million in 2022 and a CAGR of 7.8%, the industry demonstrates strong growth potential. Major global manufacturers like Medtronic plc, Boston Scientific Corporation, Abbott Laboratories, Cardinal Health, B. Braun Melsungen AG, and others are at the forefront of developing advanced drug-eluting technologies. As the demand for peripheral interventions increases, driven by aging populations and advancements in treatment options, the future of the Peripheral Intervention Drug-Eluting Devices industry appears promising.
The SWOT analysis of the Peripheral Intervention Drug-Eluting Devices industry is as follows:
Strengths:
Efficacy in Preventing Restenosis: Peripheral Intervention Drug-Eluting Devices offer a significant advantage in preventing restenosis (re-narrowing of blood vessels) compared to non-drug-eluting devices, leading to improved patient outcomes.
Technological Advancements: Continuous advancements in drug-eluting technologies enhance the precision, effectiveness, and durability of peripheral intervention devices, providing better treatment options for patients.
Market Dominance of Key Players: Major global manufacturers such as Medtronic, Boston Scientific, and Abbott Laboratories hold significant market share, benefiting from established brand reputation, extensive product portfolios, and strong distribution networks.
Weaknesses:
High Development Costs: Developing and commercializing drug-eluting devices require substantial investments in research and development, regulatory approvals, and clinical trials, which can hinder smaller players from entering the market.
Potential Side Effects: Despite their effectiveness, drug-eluting devices may carry the risk of adverse reactions to the drugs released, necessitating careful patient selection and monitoring.
Limited Application Scope: Peripheral Intervention Drug-Eluting Devices are primarily used in specific peripheral interventions, such as vascular and neurology procedures, limiting their application in other medical specialties.
Opportunities:
Growing Aging Population: The increasing aging population worldwide is expected to drive the demand for peripheral interventions, creating opportunities for the growth of the Peripheral Intervention Drug-Eluting Devices industry.
Emerging Markets: Expansion of healthcare infrastructure and rising disposable incomes in emerging markets provide untapped opportunities for market penetration and revenue growth.
Technological Innovations: Ongoing advancements in drug-eluting technologies, including new coatings, drug formulations, and delivery systems, open doors for the development of more effective and targeted peripheral intervention devices.
Threats:
Regulatory Challenges: Strict regulations and lengthy approval processes imposed by regulatory bodies can delay product launches and increase compliance costs, posing challenges for manufacturers.
Competition from Non-Drug-Eluting Devices: Non-drug-eluting devices, such as bare-metal stents and standard balloons, continue to be used in peripheral interventions, representing potential competition for drug-eluting devices.
Economic Uncertainty: Economic fluctuations, healthcare reimbursement policies, and budget constraints may impact the adoption and affordability of drug-eluting devices, affecting market growth.
Key players in global Peripheral Intervention Drug-Eluting Devices market include:
Medtronic plc
Boston Scientific Corporation
Abbott Laboratories
Cardinal Health
B. Braun Melsungen AG
Biosensors International Group Ltd.
C.R. Bard, Inc.
St. Jude Medical, Inc.
The Lubrizol Corporation
Terumo Corporation
Market segmentation, by product types:
Plain Old Balloon Angioplasty (POBA)
Percutaneous Transluminal Angioplasty (PTA)
Market segmentation, by applications:
Drug-Eluting Balloons
Drug-Eluting Stents
1 Industry Overview of Peripheral Intervention Drug-Eluting Devices
1.1 Research Scope
1.2 Market Segmentation by Types of Peripheral Intervention Drug-Eluting Devices
1.3 Market Segmentation by End Users of Peripheral Intervention Drug-Eluting Devices
1.4 Market Dynamics Analysis of Peripheral Intervention Drug-Eluting Devices
1.4.1 Market Drivers
1.4.2 Market Challenges
1.4.3 Market Opportunities
1.4.4 Porter’s Five Forces
2 Major Manufacturers Analysis of Peripheral Intervention Drug-Eluting Devices Industry
2.1 Medtronic plc
2.1.1 Company Overview
2.1.2 Main Products and Specifications
2.1.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.1.4 Contact Information
2.2 Boston Scientific Corporation
2.2.1 Company Overview
2.2.2 Main Products and Specifications
2.2.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.2.4 Contact Information
2.3 Abbott Laboratories
2.3.1 Company Overview
2.3.2 Main Products and Specifications
2.3.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.3.4 Contact Information
2.4 Cardinal Health
2.4.1 Company Overview
2.4.2 Main Products and Specifications
2.4.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.4.4 Contact Information
2.5 B. Braun Melsungen AG
2.5.1 Company Overview
2.5.2 Main Products and Specifications
2.5.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.5.4 Contact Information
2.6 Biosensors International Group Ltd.
2.6.1 Company Overview
2.6.2 Main Products and Specifications
2.6.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.6.4 Contact Information
2.7 C.R. Bard, Inc.
2.7.1 Company Overview
2.7.2 Main Products and Specifications
2.7.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.7.4 Contact Information
2.8 St. Jude Medical, Inc.
2.8.1 Company Overview
2.8.2 Main Products and Specifications
2.8.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.8.4 Contact Information
2.9 The Lubrizol Corporation
2.9.1 Company Overview
2.9.2 Main Products and Specifications
2.9.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.9.4 Contact Information
2.10 Terumo Corporation
2.10.1 Company Overview
2.10.2 Main Products and Specifications
2.10.3 Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Price and Gross Margin (2018-2023)
2.10.4 Contact Information
3 Global Peripheral Intervention Drug-Eluting Devices Market Analysis by Regions, Manufacturers, Types and End Users
3.1 Global Sales Volume and Revenue of Peripheral Intervention Drug-Eluting Devices by Regions (2018-2023)
3.2 Global Sales Volume and Revenue of Peripheral Intervention Drug-Eluting Devices by Manufacturers (2018-2023)
3.3 Global Sales Volume and Revenue of Peripheral Intervention Drug-Eluting Devices by Types (2018-2023)
3.4 Global Sales Volume and Revenue of Peripheral Intervention Drug-Eluting Devices by End Users (2018-2023)
3.5 Selling Price Analysis of Peripheral Intervention Drug-Eluting Devices by Regions, Manufacturers, Types and End Users in (2018-2023)
4 Northern America Peripheral Intervention Drug-Eluting Devices Market Analysis by Countries, Types and End Users
4.1 Northern America Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
4.2 Northern America Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Types (2018-2023)
4.3 Northern America Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
4.4 United States Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
4.5 Canada Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5 Europe Peripheral Intervention Drug-Eluting Devices Market Analysis by Countries, Types and End Users
5.1 Europe Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
5.2 Europe Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Types (2018-2023)
5.3 Europe Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
5.4 Germany Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.5 France Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.6 UK Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.7 Italy Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.8 Russia Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.9 Spain Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
5.10 Netherlands Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6 Asia Pacific Peripheral Intervention Drug-Eluting Devices Market Analysis by Countries, Types and End Users
6.1 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
6.2 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Types (2018-2023)
6.3 Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
6.4 China Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.5 Japan Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.6 Korea Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.7 India Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.8 Australia Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.9 Indonesia Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
6.10 Vietnam Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7 Latin America Peripheral Intervention Drug-Eluting Devices Market Analysis by Countries, Types and End Users
7.1 Latin America Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
7.2 Latin America Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Types (2018-2023)
7.3 Latin America Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
7.4 Brazil Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.5 Mexico Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.6 Argentina Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
7.7 Colombia Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Market Analysis by Countries, Types and End Users
8.1 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Countries (2018-2023)
8.2 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by Types (2018-2023)
8.3 Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Volume and Revenue Analysis by End Users (2018-2023)
8.4 Turkey Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.5 Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.6 South Africa Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
8.7 Egypt Peripheral Intervention Drug-Eluting Devices Sales Volume, Revenue, Import and Export Analysis (2018-2023)
9 Marketing Channel, Distributors and Traders Analysis
9.1 Marketing Channel
9.1.1 Direct Channel
9.1.2 Indirect Channel
9.2 Distributors and Traders
10 Global Peripheral Intervention Drug-Eluting Devices Market Forecast by Regions, Countries, Manufacturers, Types and End Users
10.1 Global Sales Volume and Revenue Forecast of Peripheral Intervention Drug-Eluting Devices by Regions (2024-2029)
10.2 Global Sales Volume and Revenue Forecast of Peripheral Intervention Drug-Eluting Devices by Types (2024-2029)
10.3 Global Sales Volume and Revenue Forecast of Peripheral Intervention Drug-Eluting Devices by End Users (2024-2029)
10.4 Global Revenue Forecast of Peripheral Intervention Drug-Eluting Devices by Countries (2024-2029)
10.4.1 United States Revenue Forecast (2024-2029)
10.4.2 Canada Revenue Forecast (2024-2029)
10.4.3 Germany Revenue Forecast (2024-2029)
10.4.4 France Revenue Forecast (2024-2029)
10.4.5 UK Revenue Forecast (2024-2029)
10.4.6 Italy Revenue Forecast (2024-2029)
10.4.7 Russia Revenue Forecast (2024-2029)
10.4.8 Spain Revenue Forecast (2024-2029)
10.4.9 Netherlands Revenue Forecast (2024-2029)
10.4.10 China Revenue Forecast (2024-2029)
10.4.11 Japan Revenue Forecast (2024-2029)
10.4.12 Korea Revenue Forecast (2024-2029)
10.4.13 India Revenue Forecast (2024-2029)
10.4.14 Australia Revenue Forecast (2024-2029)
10.4.15 Indonesia Revenue Forecast (2024-2029)
10.4.16 Vietnam Revenue Forecast (2024-2029)
10.4.17 Brazil Revenue Forecast (2024-2029)
10.4.18 Mexico Revenue Forecast (2024-2029)
10.4.19 Argentina Revenue Forecast (2024-2029)
10.4.20 Colombia Revenue Forecast (2024-2029)
10.4.21 Turkey Revenue Forecast (2024-2029)
10.4.22 Saudi Arabia Revenue Forecast (2024-2029)
10.4.23 South Africa Revenue Forecast (2024-2029)
10.4.24 Egypt Revenue Forecast (2024-2029)
11 Industry Chain Analysis of Peripheral Intervention Drug-Eluting Devices
11.1 Upstream Major Raw Materials and Equipment Suppliers Analysis of Peripheral Intervention Drug-Eluting Devices
11.1.1 Major Raw Materials Suppliers with Contact Information Analysis of Peripheral Intervention Drug-Eluting Devices
11.1.2 Major Equipment Suppliers with Contact Information Analysis of Peripheral Intervention Drug-Eluting Devices
11.2 Downstream Major Consumers Analysis of Peripheral Intervention Drug-Eluting Devices
11.3 Major Suppliers of Peripheral Intervention Drug-Eluting Devices with Contact Information
11.4 Supply Chain Relationship Analysis of Peripheral Intervention Drug-Eluting Devices
12 Peripheral Intervention Drug-Eluting Devices New Project Investment Feasibility Analysis
12.1 Peripheral Intervention Drug-Eluting Devices New Project SWOT Analysis
12.2 Peripheral Intervention Drug-Eluting Devices New Project Investment Feasibility Analysis
12.2.1 Project Name
12.2.2 Investment Budget
12.2.3 Project Product Solutions
12.2.4 Project Schedule
13 Peripheral Intervention Drug-Eluting Devices Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.2 References and Data Sources
14.2.1 Primary Sources
14.2.2 Secondary Paid Sources
14.2.3 Secondary Public Sources
14.3 Abbreviations and Units of Measurement
14.4 Author Details
14.5 Disclaimer
Table Types of Peripheral Intervention Drug-Eluting Devices
Table End Users of Peripheral Intervention Drug-Eluting Devices
Figure Market Drivers Analysis of Peripheral Intervention Drug-Eluting Devices
Figure Market Challenges Analysis of Peripheral Intervention Drug-Eluting Devices
Figure Market Opportunities Analysis of Peripheral Intervention Drug-Eluting Devices
Table Market Drivers Analysis of Peripheral Intervention Drug-Eluting Devices
Table Medtronic plc Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of Medtronic plc
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of Medtronic plc (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of Medtronic plc (2018-2023)
Table Boston Scientific Corporation Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of Boston Scientific Corporation
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of Boston Scientific Corporation (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of Boston Scientific Corporation (2018-2023)
Table Abbott Laboratories Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of Abbott Laboratories
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of Abbott Laboratories (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of Abbott Laboratories (2018-2023)
Table Cardinal Health Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of Cardinal Health
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of Cardinal Health (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of Cardinal Health (2018-2023)
Table B. Braun Melsungen AG Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of B. Braun Melsungen AG
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of B. Braun Melsungen AG (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of B. Braun Melsungen AG (2018-2023)
Table Biosensors International Group Ltd. Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of Biosensors International Group Ltd.
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of Biosensors International Group Ltd. (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of Biosensors International Group Ltd. (2018-2023)
Table C.R. Bard, Inc. Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of C.R. Bard, Inc.
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of C.R. Bard, Inc. (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of C.R. Bard, Inc. (2018-2023)
Table St. Jude Medical, Inc. Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of St. Jude Medical, Inc.
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of St. Jude Medical, Inc. (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of St. Jude Medical, Inc. (2018-2023)
Table The Lubrizol Corporation Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of The Lubrizol Corporation
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of The Lubrizol Corporation (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of The Lubrizol Corporation (2018-2023)
Table Terumo Corporation Information List
Figure Peripheral Intervention Drug-Eluting Devices Picture and Specifications of Terumo Corporation
Table Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (Million USD) and Gross Margin of Terumo Corporation (2018-2023)
Figure Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Global Market Share of Terumo Corporation (2018-2023)
Table Global Sales Volume (Unit) of Peripheral Intervention Drug-Eluting Devices by Regions (2018-2023)
Table Global Revenue (Million USD) of Peripheral Intervention Drug-Eluting Devices by Regions (2018-2023)
Table Global Sales Volume (Unit) of Peripheral Intervention Drug-Eluting Devices by Manufacturers (2018-2023)
Table Global Revenue (Million USD) of Peripheral Intervention Drug-Eluting Devices by Manufacturers (2018-2023)
Table Global Sales Volume (Unit) of Peripheral Intervention Drug-Eluting Devices by Types (2018-2023)
Table Global Revenue (Million USD) of Peripheral Intervention Drug-Eluting Devices by Types (2018-2023)
Table Global Sales Volume (Unit) of Peripheral Intervention Drug-Eluting Devices by End Users (2018-2023)
Table Global Revenue (Million USD) of Peripheral Intervention Drug-Eluting Devices by End Users (2018-2023)
Table Selling Price Comparison of Global Peripheral Intervention Drug-Eluting Devices by Regions in (2018-2023) (USD/Unit)
Table Selling Price Comparison of Global Peripheral Intervention Drug-Eluting Devices by Manufacturers in (2018-2023) (USD/Unit)
Table Selling Price Comparison of Global Peripheral Intervention Drug-Eluting Devices by Types in (2018-2023) (USD/Unit)
Table Selling Price Comparison of Global Peripheral Intervention Drug-Eluting Devices by End Users in (2018-2023) (USD/Unit)
Table Northern America Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Countries (2018-2023)
Table Northern America Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Countries (2018-2023)
Table Northern America Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Types (2018-2023)
Table Northern America Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Types (2018-2023)
Table Northern America Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by End Users (2018-2023)
Table Northern America Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by End Users (2018-2023)
Table United States Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure United States Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure United States Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Canada Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Canada Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Canada Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Countries (2018-2023)
Table Europe Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Countries (2018-2023)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Types (2018-2023)
Table Europe Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Types (2018-2023)
Table Europe Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by End Users (2018-2023)
Table Europe Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by End Users (2018-2023)
Table Germany Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Germany Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Germany Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table France Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure France Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure France Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table UK Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure UK Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure UK Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Italy Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Italy Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Italy Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Russia Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Russia Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Russia Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Spain Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Spain Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Spain Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Netherlands Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Netherlands Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Netherlands Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Countries (2018-2023)
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Countries (2018-2023)
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Types (2018-2023)
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Types (2018-2023)
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by End Users (2018-2023)
Table Asia Pacific Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by End Users (2018-2023)
Table China Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure China Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure China Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Japan Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Japan Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Japan Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Korea Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Korea Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Korea Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table India Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure India Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure India Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Australia Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Australia Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Australia Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Indonesia Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Indonesia Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Indonesia Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Vietnam Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Vietnam Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Vietnam Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Latin America Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Countries (2018-2023)
Table Latin America Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Countries (2018-2023)
Table Latin America Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Types (2018-2023)
Table Latin America Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Types (2018-2023)
Table Latin America Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by End Users (2018-2023)
Table Latin America Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by End Users (2018-2023)
Table Brazil Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Brazil Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Brazil Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Mexico Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Mexico Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Argentina Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Argentina Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Argentina Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Colombia Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Colombia Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Colombia Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Countries (2018-2023)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Countries (2018-2023)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by Types (2018-2023)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by Types (2018-2023)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) by End Users (2018-2023)
Table Middle East & Africa Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) by End Users (2018-2023)
Table Turkey Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Turkey Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Turkey Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Saudi Arabia Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Saudi Arabia Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table South Africa Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure South Africa Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Egypt Peripheral Intervention Drug-Eluting Devices Import and Export (Unit) (2018-2023)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Sales Volume (Unit) and Growth Rate (2018-2023)
Figure Egypt Peripheral Intervention Drug-Eluting Devices Revenue (Million USD) and Growth Rate (2018-2023)
Table Global Sales Volume (Unit) Forecast of Peripheral Intervention Drug-Eluting Devices by Regions (2024-2029)
Table Global Revenue (Million USD) Forecast of Peripheral Intervention Drug-Eluting Devices by Regions (2024-2029)
Table Global Sales Volume (Unit) Forecast of Peripheral Intervention Drug-Eluting Devices by Types (2024-2029)
Table Global Revenue (Million USD) Forecast of Peripheral Intervention Drug-Eluting Devices by Types (2024-2029)
Table Global Sales Volume (Unit) Forecast of Peripheral Intervention Drug-Eluting Devices by End Users (2024-2029)
Table Global Revenue (Million USD) Forecast of Peripheral Intervention Drug-Eluting Devices by End Users (2024-2029)
Table Major Raw Materials Suppliers with Contact Information of Peripheral Intervention Drug-Eluting Devices
Table Major Equipment Suppliers with Contact Information of Peripheral Intervention Drug-Eluting Devices
Table Major Consumers with Contact Information of Peripheral Intervention Drug-Eluting Devices
Table Major Suppliers of Peripheral Intervention Drug-Eluting Devices with Contact Information
Figure Supply Chain Relationship Analysis of Peripheral Intervention Drug-Eluting Devices
Table New Project SWOT Analysis of Peripheral Intervention Drug-Eluting Devices
Table Project Appraisal and Financing
Table New Project Construction Period
Table New Project Investment Feasibility Analysis of Peripheral Intervention Drug-Eluting Devices
Table Research Programs/Design for This Report
Table Key Data Information from Primary Sources
Table Key Data Information from Secondary Sources
Table Part of Interviewees Record List of Peripheral Intervention Drug-Eluting Devices Industry
Table Part of References List of Peripheral Intervention Drug-Eluting Devices Industry
Table Units of Measurement List
Table Part of Author Details List of Peripheral Intervention Drug-Eluting Devices Industry
HJ Research employs comprehensive and iterative research methodology focused on minimizing deviance in order to provide the most accurate estimates and forecast possible. At HJ Research, our researchers and domain experts use a unique blend of primary and secondary research, with validation and iterations at every stage, in order to minimize deviation and present the most accurate analysis of the Peripheral Intervention Drug-Eluting Devices industry. Critical elements of methodology employed for all our studies include:
Secondary Sources:
The research team first works with national bureau of statistics, national customs, market research association, state information center, and administration that operate in the research field. The information provided by our in-house documentation service helps us carrying out further research. Secondary sources are mainly from press releases, company reports and publications, non-profit organizations, industry associations, government publications, economic and demographic data and customs data. In addition, data is also mined from a host of reports in our repository, as well as a number of reputed paid databases. Our team which has the experience as well as the knowledge efficiently extracts the accurate information from existing source.
Primary Research:
In the primary research process, for comprehensive understanding of the Peripheral Intervention Drug-Eluting Devices market, it is essential to understand the complete value chain and in order to facilitate this, we collect data from Peripheral Intervention Drug-Eluting Devices manufacturers, Peripheral Intervention Drug-Eluting Devices raw material suppliers, Peripheral Intervention Drug-Eluting Devices distributors as well as buyers. The primary sources from the supply side include Peripheral Intervention Drug-Eluting Devices manufacturers, opinion leaders, industry experts, research institutions, distributors, dealer and traders, as well as the Peripheral Intervention Drug-Eluting Devices raw materials suppliers and producers, etc. The primary sources from the demand side include industry experts such as business leaders, marketing and sales directors, technology and innovation directors, supply chain executive, end users, and related key executives from various key companies and organizations operating in the global market.
Technical issues and trends are obtained from surveys, technical symposia and trade journals. Technical data is also gathered from intellectual property perspective, focusing on white space and freedom of movement. Industry dynamics with respect to drivers, restraints, pricing trends are also gathered.
Statistical Model and Data Analysis:
Our market estimates and forecasts are derived through simulation models. A unique model is created customized for each study. Gathered information for market dynamics, technology landscape, application development and pricing trends is fed into the model and analyzed simultaneously. These factors are studied on a comparative basis, and their impact over the forecast period is quantified with the help of correlation, regression and time series analysis. Market forecasting is performed via a combination of economic tools, technological analysis, and industry experience and domain expertise. Qualitative analysis includes: Peripheral Intervention Drug-Eluting Devices industry landscape and trends, Peripheral Intervention Drug-Eluting Devices market dynamics and key issues, Peripheral Intervention Drug-Eluting Devices technology landscape, market opportunities, porter’s analysis and PESTEL analysis, Peripheral Intervention Drug-Eluting Devices competitive landscape and component benchmarking, policy and regulatory scenario. Quantitative analysis includes: Peripheral Intervention Drug-Eluting Devices market size and forecast by regions, Peripheral Intervention Drug-Eluting Devices market size and forecast by application, Peripheral Intervention Drug-Eluting Devices market size and forecast by types, Peripheral Intervention Drug-Eluting Devices company market share etc.
Quality Control:
Before publishing, every report goes under a rigorous checking and editing process, which is done by experience management team to ensure the reliability of the published data. Each analyst in the research team receives support and on-going training which is part of the HJ Research’s internal quality process.
